SCHEMBL21964570

SCHEMBL21964570

CCOC(=O)c1cc(N)n(CC(C)C)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 2/20 0.51
ALDH1A1 P00352 6/20 0.41
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
NPC1 O15118 1/20 0.41
MAPT P10636 1/20 0.41
RAB9A P51151 1/20 0.41
CYP1A2 P05177 1/20 0.41
MAPK1 P28482 4/20 0.40
POLB P06746 3/20 0.40
KDM4E B2RXH2 1/20 0.40
PDE4D Q08499 1/20 0.39
TSHR P16473 1/20 0.39
GAA P10253 1/20 0.39
ADORA3 P0DMS8 1/20 0.39
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
LMNA P02545 1/20 0.39
HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21960379 0.86 ALDH1A1 (0.43) NR1H2ALDH1A1KMT2AMEN1NPC1
SCHEMBL1738098 0.85 KMT2A (0.45) ALDH1A1KMT2AMEN1NPC1MAPT
SCHEMBL22412843 0.82 NR1H2 (0.53) NR1H2ALDH1A1KMT2AMAPTCYP1A2
SCHEMBL31691141 0.80 APAF1 (0.37) ALDH1A1POLBSMN1; SMN2LMNA
SCHEMBL21964579 0.79 ADORA3 (0.46) ALDH1A1KMT2AMEN1NPC1MAPT
SCHEMBL14357201 0.79 KMT2A (0.43) ALDH1A1KMT2AMEN1NPC1MAPT
SCHEMBL12100567 0.79 CNR2 (0.45) ALDH1A1KMT2AMEN1NPC1MAPT
SCHEMBL21964575 0.79 ALDH1A1 (0.43) ALDH1A1KMT2AMEN1NPC1MAPT
SCHEMBL4705103 0.78 ALDH1A1 (0.43) ALDH1A1KMT2AMEN1NPC1MAPT
SCHEMBL4010000 0.78 NR1H2 (0.72) NR1H2ALDH1A1KMT2ANPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250304567-A1 PYRROLIDIONE DERIVATIVES AS INHIBITORS OF NF KAPPA B INDUCING KINASE JANSSEN PHARMACEUTICA NV (BE) 2025-10-02 US disclosed
US-11136311-B2 Heteroaromatic derivatives as NIK inhibitors JANSSEN PHARMACEUTICA NV (BE) 2021-10-05 US disclosed
EP-3478675-B1 HETEROAROMATIC DERIVATIVES AS NIK INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2020-04-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250304567-A1 PYRROLIDIONE DERIVATIVES AS INHIBITORS OF NF KAPPA B INDUCING KINASE NFKBIA, IKBKG, IKBKB NR1H2 804/4885ALDH1A1 4233/4885KMT2A 4079/4885
US-11136311-B2 Heteroaromatic derivatives as NIK inhibitors NFKBIA, IKBKG, IKBKE NR1H2 337/4885ALDH1A1 3872/4885KMT2A 1706/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.